110 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SRPT Sarepta Therapeutics, Inc. $152.52 $10.13B N/A
Article Searches
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy? https://www.fool.com/investing/2019/06/09/gene-therapy-vs-gene-editing-which-is-better-for-t.aspx?source=iedfolrf0000001 Jun 09, 2019 - Vertex Pharmaceuticals recently doubled down on its gene editing collaboration with CRISPR Therapeutics, but it's miles behind an arguably simpler solution.
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4263084-sarepta-therapeutics-inc-srpt-ceo-douglas-ingram-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 11, 2019 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Ian Estepan - Senior Vice President, Chief of Staff and Corporate Affairs Douglas
Sarepta Therapeutics (SRPT) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/10/sarepta-therapeutics-srpt-q1-2019-earnings-call-tr.aspx?source=iedfolrf0000001 May 10, 2019 - SRPT earnings call for the period ending March 31, 2019.
Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/411314/sarepta-therapeutics-srpt-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-411314 May 08, 2019 - Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 47.81% and 0.11%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Sarepta Therapeutics (SRPT) Presents At Annual Meeting of the American Society of Gene and Cell Therapy - Slideshow https://seekingalpha.com/article/4259150-sarepta-therapeutics-srpt-presents-annual-meeting-american-society-gene-cell-therapy?source=feed_sector_healthcare May 02, 2019 - The following slide deck was published by Sarepta Therapeutics, Inc. in conjunction with this event.
What's in the Cards for Sarepta (SRPT) This Earnings Season? http://www.zacks.com/stock/news/404867/whats-in-the-cards-for-sarepta-srpt-this-earnings-season?cid=CS-ZC-FT-404867 Apr 29, 2019 - Sarepta Therapeutics' (SRPT) Exondys 51 likely to drive first-quarter sales.
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release http://www.zacks.com/stock/news/401131/sarepta-therapeutics-srpt-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release?cid=CS-ZC-FT-401131 Apr 25, 2019 - Sarepta Therapeutics (SRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Stocks Warren Buffett Would Love https://www.fool.com/investing/2019/04/23/3-stocks-warren-buffett-would-love.aspx?source=iedfolrf0000001 Apr 23, 2019 - Want to invest like the great value investor? These stocks might appeal to you.
Wave Life Sciences Plunges After DMD Study Data Readout http://www.zacks.com/stock/news/386326/wave-life-sciences-plunges-after-dmd-study-data-readout?cid=CS-ZC-FT-386326 Apr 17, 2019 - Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage development of the candidate.
4 Gene Therapy Players Likely to Become Buyout Targets in 2019 http://www.zacks.com/stock/news/372303/4-gene-therapy-players-likely-to-become-buyout-targets-in-2019?cid=CS-ZC-FT-372303 Apr 08, 2019 - Gene therapy continues to be in focus given the recent spate of deals and acquisitions. We highlight four stocks, which have promising gene therapy candidates in their pipeline.

Pages: 123456...11

Page 1>